Sovran Advisors’s GSK GSK Stock Holding History

Sovran Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$268K	Buy	4,982 +1,002	+25%	+$53K	0.02%	513
2026 Q1	$208K	Buy	+3,980	New	+$216K	0.02%	556

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Sovran Advisors's GSK Position: Q2 2026 in Review

Sovran Advisors increased its GSK (GSK) stake by 25% in Q2 2026, buying an estimated $53K and bringing the position to 4,982 shares worth $268K. The position accounts for 0.02% of the portfolio, ranked #513.

Sovran Advisors first reported a position in GSK in Q1 2026 and has held it in 2 quarters since. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Sovran Advisors held 4,982 shares of GSK worth $268K as of Q2 2026.
Sovran Advisors bought 1,002 GSK shares in Q2 2026, an estimated $53K.
GSK made up 0.02% of Sovran Advisors's portfolio in Q2 2026, its #513 holding.
Sovran Advisors first reported a position in GSK in Q1 2026 and has held it in 2 quarters since.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Sovran Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.